Anti-neutrophil cytoplasmic antibodies (ANCA) with BPI specificity have been identified in different diseases associated with Gram-negative bacteria, such as inflammatory bowel diseases (IBD) and primary sclerosing cholangitis [14], and are frequently present in CF patients [11, 15, 16]. This evidence concerns the gene BPI and inflammatory bowel disease.